IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1091611, encodeId=f7f610916114e, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091612, encodeId=94391091612f5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856940, encodeId=cc5a8569405b, content=审稿速度:1.0 经验分享：投tip被拒后，直接改投tbme，一审36天，拒稿重投，但其实2个审稿人没有给太多意见，修了2个月左右返回，二审21天直接接受。总体感觉还不错，但由于收稿范围很广，碰到小同行的概率相对较低。此外，比较好奇6楼怎么判断审稿意见是大修还是小修，审稿意见没有明确标注。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Jan 17 17:46:59 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850431, encodeId=9a9c850431b7, content=生物医学工程领域的老牌期刊，级别较高，影响力大，圈内认可度高。本次投稿很幸运能够录用，一审两个月，两个审稿人提了很多意见，编辑给的major revision。第二次审了三个月和直接录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Fri Mar 22 22:47:17 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846882, encodeId=16cb84688257, content=很幸运能够录用。编辑和审稿人（共两个审稿人）都很nice，2018年4月29日投稿，5月29日返回审稿意见（一个小修，一个大修），编辑给的大修；7月6日投回，8月14日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Sun Sep 02 10:56:47 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553850, encodeId=ab2955385017, content=您好.期刊***址有吗?我找不到zagzlh 2011-06-28 15:50:00 发表: , beContent=zagzlh 2011-06-28 15:50:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a0e2229174, createdName=2453381967_77778861, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839456, encodeId=a9d683945671, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：已经三个星期了，一直under review……不知道要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Wed Nov 22 10:27:44 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839359, encodeId=e75f83935981, content=审稿速度:1.0 经验分享：期刊很不错，值得一投。审稿人意见很中肯，需要足够的创新性！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Thu Nov 16 17:20:39 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835621, encodeId=b849835621b8, content=很好的期刊，工程领域影响力比较大，编辑和审稿人（共两个审稿人）都很专业，也很负责，2016年9月25日投稿，11月12日返回审稿意见（一个中修，一个大修），编辑给的大修；2017年1月11日投回，2月14日返回审稿意见（一个接收，一个小修），编辑给的小修；2月16日投回，2月21日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Wed Feb 22 15:39:33 CST 2017, time=2017-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833455, encodeId=08358334557a, content=创新性不足，直接拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4935414017, createdName=ms7761655755119078, createdTime=Thu Aug 25 10:31:21 CST 2016, time=2016-08-25, status=1, ipAttribution=)]

2021-12-29 msSSSSSD

选刊时有哪些需要避免的雷区？

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1091611, encodeId=f7f610916114e, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091612, encodeId=94391091612f5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856940, encodeId=cc5a8569405b, content=审稿速度:1.0 经验分享：投tip被拒后，直接改投tbme，一审36天，拒稿重投，但其实2个审稿人没有给太多意见，修了2个月左右返回，二审21天直接接受。总体感觉还不错，但由于收稿范围很广，碰到小同行的概率相对较低。此外，比较好奇6楼怎么判断审稿意见是大修还是小修，审稿意见没有明确标注。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Jan 17 17:46:59 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850431, encodeId=9a9c850431b7, content=生物医学工程领域的老牌期刊，级别较高，影响力大，圈内认可度高。本次投稿很幸运能够录用，一审两个月，两个审稿人提了很多意见，编辑给的major revision。第二次审了三个月和直接录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Fri Mar 22 22:47:17 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846882, encodeId=16cb84688257, content=很幸运能够录用。编辑和审稿人（共两个审稿人）都很nice，2018年4月29日投稿，5月29日返回审稿意见（一个小修，一个大修），编辑给的大修；7月6日投回，8月14日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Sun Sep 02 10:56:47 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553850, encodeId=ab2955385017, content=您好.期刊***址有吗?我找不到zagzlh 2011-06-28 15:50:00 发表: , beContent=zagzlh 2011-06-28 15:50:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a0e2229174, createdName=2453381967_77778861, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839456, encodeId=a9d683945671, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：已经三个星期了，一直under review……不知道要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Wed Nov 22 10:27:44 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839359, encodeId=e75f83935981, content=审稿速度:1.0 经验分享：期刊很不错，值得一投。审稿人意见很中肯，需要足够的创新性！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Thu Nov 16 17:20:39 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835621, encodeId=b849835621b8, content=很好的期刊，工程领域影响力比较大，编辑和审稿人（共两个审稿人）都很专业，也很负责，2016年9月25日投稿，11月12日返回审稿意见（一个中修，一个大修），编辑给的大修；2017年1月11日投回，2月14日返回审稿意见（一个接收，一个小修），编辑给的小修；2月16日投回，2月21日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Wed Feb 22 15:39:33 CST 2017, time=2017-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833455, encodeId=08358334557a, content=创新性不足，直接拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4935414017, createdName=ms7761655755119078, createdTime=Thu Aug 25 10:31:21 CST 2016, time=2016-08-25, status=1, ipAttribution=)]

2021-12-29 ms6000000264964247

哪些期刊是公认的水刊？

42 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1091611, encodeId=f7f610916114e, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091612, encodeId=94391091612f5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856940, encodeId=cc5a8569405b, content=审稿速度:1.0 经验分享：投tip被拒后，直接改投tbme，一审36天，拒稿重投，但其实2个审稿人没有给太多意见，修了2个月左右返回，二审21天直接接受。总体感觉还不错，但由于收稿范围很广，碰到小同行的概率相对较低。此外，比较好奇6楼怎么判断审稿意见是大修还是小修，审稿意见没有明确标注。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Jan 17 17:46:59 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850431, encodeId=9a9c850431b7, content=生物医学工程领域的老牌期刊，级别较高，影响力大，圈内认可度高。本次投稿很幸运能够录用，一审两个月，两个审稿人提了很多意见，编辑给的major revision。第二次审了三个月和直接录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Fri Mar 22 22:47:17 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846882, encodeId=16cb84688257, content=很幸运能够录用。编辑和审稿人（共两个审稿人）都很nice，2018年4月29日投稿，5月29日返回审稿意见（一个小修，一个大修），编辑给的大修；7月6日投回，8月14日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Sun Sep 02 10:56:47 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553850, encodeId=ab2955385017, content=您好.期刊***址有吗?我找不到zagzlh 2011-06-28 15:50:00 发表: , beContent=zagzlh 2011-06-28 15:50:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a0e2229174, createdName=2453381967_77778861, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839456, encodeId=a9d683945671, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：已经三个星期了，一直under review……不知道要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Wed Nov 22 10:27:44 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839359, encodeId=e75f83935981, content=审稿速度:1.0 经验分享：期刊很不错，值得一投。审稿人意见很中肯，需要足够的创新性！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Thu Nov 16 17:20:39 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835621, encodeId=b849835621b8, content=很好的期刊，工程领域影响力比较大，编辑和审稿人（共两个审稿人）都很专业，也很负责，2016年9月25日投稿，11月12日返回审稿意见（一个中修，一个大修），编辑给的大修；2017年1月11日投回，2月14日返回审稿意见（一个接收，一个小修），编辑给的小修；2月16日投回，2月21日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Wed Feb 22 15:39:33 CST 2017, time=2017-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833455, encodeId=08358334557a, content=创新性不足，直接拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4935414017, createdName=ms7761655755119078, createdTime=Thu Aug 25 10:31:21 CST 2016, time=2016-08-25, status=1, ipAttribution=)]

2020-01-17 ms903640464789830

审稿速度:1.0
经验分享：投tip被拒后，直接改投tbme，一审36天，拒稿重投，但其实2个审稿人没有给太多意见，修了2个月左右返回，二审21天直接接受。总体感觉还不错，但由于收稿范围很广，碰到小同行的概率相对较低。此外，比较好奇6楼怎么判断审稿意见是大修还是小修，审稿意见没有明确标注。

79 0

[GetPortalCommentsPageByObjectIdResponse(id=1091611, encodeId=f7f610916114e, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091612, encodeId=94391091612f5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856940, encodeId=cc5a8569405b, content=审稿速度:1.0 经验分享：投tip被拒后，直接改投tbme，一审36天，拒稿重投，但其实2个审稿人没有给太多意见，修了2个月左右返回，二审21天直接接受。总体感觉还不错，但由于收稿范围很广，碰到小同行的概率相对较低。此外，比较好奇6楼怎么判断审稿意见是大修还是小修，审稿意见没有明确标注。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Jan 17 17:46:59 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850431, encodeId=9a9c850431b7, content=生物医学工程领域的老牌期刊，级别较高，影响力大，圈内认可度高。本次投稿很幸运能够录用，一审两个月，两个审稿人提了很多意见，编辑给的major revision。第二次审了三个月和直接录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Fri Mar 22 22:47:17 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846882, encodeId=16cb84688257, content=很幸运能够录用。编辑和审稿人（共两个审稿人）都很nice，2018年4月29日投稿，5月29日返回审稿意见（一个小修，一个大修），编辑给的大修；7月6日投回，8月14日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Sun Sep 02 10:56:47 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553850, encodeId=ab2955385017, content=您好.期刊***址有吗?我找不到zagzlh 2011-06-28 15:50:00 发表: , beContent=zagzlh 2011-06-28 15:50:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a0e2229174, createdName=2453381967_77778861, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839456, encodeId=a9d683945671, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：已经三个星期了，一直under review……不知道要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Wed Nov 22 10:27:44 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839359, encodeId=e75f83935981, content=审稿速度:1.0 经验分享：期刊很不错，值得一投。审稿人意见很中肯，需要足够的创新性！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Thu Nov 16 17:20:39 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835621, encodeId=b849835621b8, content=很好的期刊，工程领域影响力比较大，编辑和审稿人（共两个审稿人）都很专业，也很负责，2016年9月25日投稿，11月12日返回审稿意见（一个中修，一个大修），编辑给的大修；2017年1月11日投回，2月14日返回审稿意见（一个接收，一个小修），编辑给的小修；2月16日投回，2月21日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Wed Feb 22 15:39:33 CST 2017, time=2017-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833455, encodeId=08358334557a, content=创新性不足，直接拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4935414017, createdName=ms7761655755119078, createdTime=Thu Aug 25 10:31:21 CST 2016, time=2016-08-25, status=1, ipAttribution=)]

2019-03-22 ms8933482113232354

生物医学工程领域的老牌期刊，级别较高，影响力大，圈内认可度高。本次投稿很幸运能够录用，一审两个月，两个审稿人提了很多意见，编辑给的major revision。第二次审了三个月和直接录用。

81 0

[GetPortalCommentsPageByObjectIdResponse(id=1091611, encodeId=f7f610916114e, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091612, encodeId=94391091612f5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856940, encodeId=cc5a8569405b, content=审稿速度:1.0 经验分享：投tip被拒后，直接改投tbme，一审36天，拒稿重投，但其实2个审稿人没有给太多意见，修了2个月左右返回，二审21天直接接受。总体感觉还不错，但由于收稿范围很广，碰到小同行的概率相对较低。此外，比较好奇6楼怎么判断审稿意见是大修还是小修，审稿意见没有明确标注。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Jan 17 17:46:59 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850431, encodeId=9a9c850431b7, content=生物医学工程领域的老牌期刊，级别较高，影响力大，圈内认可度高。本次投稿很幸运能够录用，一审两个月，两个审稿人提了很多意见，编辑给的major revision。第二次审了三个月和直接录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Fri Mar 22 22:47:17 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846882, encodeId=16cb84688257, content=很幸运能够录用。编辑和审稿人（共两个审稿人）都很nice，2018年4月29日投稿，5月29日返回审稿意见（一个小修，一个大修），编辑给的大修；7月6日投回，8月14日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Sun Sep 02 10:56:47 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553850, encodeId=ab2955385017, content=您好.期刊***址有吗?我找不到zagzlh 2011-06-28 15:50:00 发表: , beContent=zagzlh 2011-06-28 15:50:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a0e2229174, createdName=2453381967_77778861, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839456, encodeId=a9d683945671, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：已经三个星期了，一直under review……不知道要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Wed Nov 22 10:27:44 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839359, encodeId=e75f83935981, content=审稿速度:1.0 经验分享：期刊很不错，值得一投。审稿人意见很中肯，需要足够的创新性！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Thu Nov 16 17:20:39 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835621, encodeId=b849835621b8, content=很好的期刊，工程领域影响力比较大，编辑和审稿人（共两个审稿人）都很专业，也很负责，2016年9月25日投稿，11月12日返回审稿意见（一个中修，一个大修），编辑给的大修；2017年1月11日投回，2月14日返回审稿意见（一个接收，一个小修），编辑给的小修；2月16日投回，2月21日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Wed Feb 22 15:39:33 CST 2017, time=2017-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833455, encodeId=08358334557a, content=创新性不足，直接拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4935414017, createdName=ms7761655755119078, createdTime=Thu Aug 25 10:31:21 CST 2016, time=2016-08-25, status=1, ipAttribution=)]

2018-09-02 ms8780191241558819

很幸运能够录用。编辑和审稿人（共两个审稿人）都很nice，2018年4月29日投稿，5月29日返回审稿意见（一个小修，一个大修），编辑给的大修；7月6日投回，8月14日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！

71 0

[GetPortalCommentsPageByObjectIdResponse(id=1091611, encodeId=f7f610916114e, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091612, encodeId=94391091612f5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856940, encodeId=cc5a8569405b, content=审稿速度:1.0 经验分享：投tip被拒后，直接改投tbme，一审36天，拒稿重投，但其实2个审稿人没有给太多意见，修了2个月左右返回，二审21天直接接受。总体感觉还不错，但由于收稿范围很广，碰到小同行的概率相对较低。此外，比较好奇6楼怎么判断审稿意见是大修还是小修，审稿意见没有明确标注。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Jan 17 17:46:59 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850431, encodeId=9a9c850431b7, content=生物医学工程领域的老牌期刊，级别较高，影响力大，圈内认可度高。本次投稿很幸运能够录用，一审两个月，两个审稿人提了很多意见，编辑给的major revision。第二次审了三个月和直接录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Fri Mar 22 22:47:17 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846882, encodeId=16cb84688257, content=很幸运能够录用。编辑和审稿人（共两个审稿人）都很nice，2018年4月29日投稿，5月29日返回审稿意见（一个小修，一个大修），编辑给的大修；7月6日投回，8月14日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Sun Sep 02 10:56:47 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553850, encodeId=ab2955385017, content=您好.期刊***址有吗?我找不到zagzlh 2011-06-28 15:50:00 发表: , beContent=zagzlh 2011-06-28 15:50:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a0e2229174, createdName=2453381967_77778861, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839456, encodeId=a9d683945671, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：已经三个星期了，一直under review……不知道要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Wed Nov 22 10:27:44 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839359, encodeId=e75f83935981, content=审稿速度:1.0 经验分享：期刊很不错，值得一投。审稿人意见很中肯，需要足够的创新性！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Thu Nov 16 17:20:39 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835621, encodeId=b849835621b8, content=很好的期刊，工程领域影响力比较大，编辑和审稿人（共两个审稿人）都很专业，也很负责，2016年9月25日投稿，11月12日返回审稿意见（一个中修，一个大修），编辑给的大修；2017年1月11日投回，2月14日返回审稿意见（一个接收，一个小修），编辑给的小修；2月16日投回，2月21日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Wed Feb 22 15:39:33 CST 2017, time=2017-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833455, encodeId=08358334557a, content=创新性不足，直接拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4935414017, createdName=ms7761655755119078, createdTime=Thu Aug 25 10:31:21 CST 2016, time=2016-08-25, status=1, ipAttribution=)]

2018-03-19 2453381967_77778861

您好.期刊***址有吗?我找不到zagzlh 2011-06-28 15:50:00 发表:

zagzlh 2011-06-28 15:50:00 发表:

261 0

[GetPortalCommentsPageByObjectIdResponse(id=1091611, encodeId=f7f610916114e, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091612, encodeId=94391091612f5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856940, encodeId=cc5a8569405b, content=审稿速度:1.0 经验分享：投tip被拒后，直接改投tbme，一审36天，拒稿重投，但其实2个审稿人没有给太多意见，修了2个月左右返回，二审21天直接接受。总体感觉还不错，但由于收稿范围很广，碰到小同行的概率相对较低。此外，比较好奇6楼怎么判断审稿意见是大修还是小修，审稿意见没有明确标注。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Jan 17 17:46:59 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850431, encodeId=9a9c850431b7, content=生物医学工程领域的老牌期刊，级别较高，影响力大，圈内认可度高。本次投稿很幸运能够录用，一审两个月，两个审稿人提了很多意见，编辑给的major revision。第二次审了三个月和直接录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Fri Mar 22 22:47:17 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846882, encodeId=16cb84688257, content=很幸运能够录用。编辑和审稿人（共两个审稿人）都很nice，2018年4月29日投稿，5月29日返回审稿意见（一个小修，一个大修），编辑给的大修；7月6日投回，8月14日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Sun Sep 02 10:56:47 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553850, encodeId=ab2955385017, content=您好.期刊***址有吗?我找不到zagzlh 2011-06-28 15:50:00 发表: , beContent=zagzlh 2011-06-28 15:50:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a0e2229174, createdName=2453381967_77778861, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839456, encodeId=a9d683945671, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：已经三个星期了，一直under review……不知道要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Wed Nov 22 10:27:44 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839359, encodeId=e75f83935981, content=审稿速度:1.0 经验分享：期刊很不错，值得一投。审稿人意见很中肯，需要足够的创新性！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Thu Nov 16 17:20:39 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835621, encodeId=b849835621b8, content=很好的期刊，工程领域影响力比较大，编辑和审稿人（共两个审稿人）都很专业，也很负责，2016年9月25日投稿，11月12日返回审稿意见（一个中修，一个大修），编辑给的大修；2017年1月11日投回，2月14日返回审稿意见（一个接收，一个小修），编辑给的小修；2月16日投回，2月21日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Wed Feb 22 15:39:33 CST 2017, time=2017-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833455, encodeId=08358334557a, content=创新性不足，直接拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4935414017, createdName=ms7761655755119078, createdTime=Thu Aug 25 10:31:21 CST 2016, time=2016-08-25, status=1, ipAttribution=)]

2017-11-22 ms8494960720180498

审稿速度:1.0 | 投稿命中率:75.0
经验分享：已经三个星期了，一直under review……不知道要等多久。

82 0

[GetPortalCommentsPageByObjectIdResponse(id=1091611, encodeId=f7f610916114e, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091612, encodeId=94391091612f5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856940, encodeId=cc5a8569405b, content=审稿速度:1.0 经验分享：投tip被拒后，直接改投tbme，一审36天，拒稿重投，但其实2个审稿人没有给太多意见，修了2个月左右返回，二审21天直接接受。总体感觉还不错，但由于收稿范围很广，碰到小同行的概率相对较低。此外，比较好奇6楼怎么判断审稿意见是大修还是小修，审稿意见没有明确标注。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Jan 17 17:46:59 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850431, encodeId=9a9c850431b7, content=生物医学工程领域的老牌期刊，级别较高，影响力大，圈内认可度高。本次投稿很幸运能够录用，一审两个月，两个审稿人提了很多意见，编辑给的major revision。第二次审了三个月和直接录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Fri Mar 22 22:47:17 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846882, encodeId=16cb84688257, content=很幸运能够录用。编辑和审稿人（共两个审稿人）都很nice，2018年4月29日投稿，5月29日返回审稿意见（一个小修，一个大修），编辑给的大修；7月6日投回，8月14日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Sun Sep 02 10:56:47 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553850, encodeId=ab2955385017, content=您好.期刊***址有吗?我找不到zagzlh 2011-06-28 15:50:00 发表: , beContent=zagzlh 2011-06-28 15:50:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a0e2229174, createdName=2453381967_77778861, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839456, encodeId=a9d683945671, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：已经三个星期了，一直under review……不知道要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Wed Nov 22 10:27:44 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839359, encodeId=e75f83935981, content=审稿速度:1.0 经验分享：期刊很不错，值得一投。审稿人意见很中肯，需要足够的创新性！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Thu Nov 16 17:20:39 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835621, encodeId=b849835621b8, content=很好的期刊，工程领域影响力比较大，编辑和审稿人（共两个审稿人）都很专业，也很负责，2016年9月25日投稿，11月12日返回审稿意见（一个中修，一个大修），编辑给的大修；2017年1月11日投回，2月14日返回审稿意见（一个接收，一个小修），编辑给的小修；2月16日投回，2月21日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Wed Feb 22 15:39:33 CST 2017, time=2017-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833455, encodeId=08358334557a, content=创新性不足，直接拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4935414017, createdName=ms7761655755119078, createdTime=Thu Aug 25 10:31:21 CST 2016, time=2016-08-25, status=1, ipAttribution=)]

2017-11-16 ms1706975392724364

审稿速度:1.0
经验分享：期刊很不错，值得一投。审稿人意见很中肯，需要足够的创新性！

81 0

[GetPortalCommentsPageByObjectIdResponse(id=1091611, encodeId=f7f610916114e, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091612, encodeId=94391091612f5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856940, encodeId=cc5a8569405b, content=审稿速度:1.0 经验分享：投tip被拒后，直接改投tbme，一审36天，拒稿重投，但其实2个审稿人没有给太多意见，修了2个月左右返回，二审21天直接接受。总体感觉还不错，但由于收稿范围很广，碰到小同行的概率相对较低。此外，比较好奇6楼怎么判断审稿意见是大修还是小修，审稿意见没有明确标注。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Jan 17 17:46:59 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850431, encodeId=9a9c850431b7, content=生物医学工程领域的老牌期刊，级别较高，影响力大，圈内认可度高。本次投稿很幸运能够录用，一审两个月，两个审稿人提了很多意见，编辑给的major revision。第二次审了三个月和直接录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Fri Mar 22 22:47:17 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846882, encodeId=16cb84688257, content=很幸运能够录用。编辑和审稿人（共两个审稿人）都很nice，2018年4月29日投稿，5月29日返回审稿意见（一个小修，一个大修），编辑给的大修；7月6日投回，8月14日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Sun Sep 02 10:56:47 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553850, encodeId=ab2955385017, content=您好.期刊***址有吗?我找不到zagzlh 2011-06-28 15:50:00 发表: , beContent=zagzlh 2011-06-28 15:50:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a0e2229174, createdName=2453381967_77778861, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839456, encodeId=a9d683945671, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：已经三个星期了，一直under review……不知道要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Wed Nov 22 10:27:44 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839359, encodeId=e75f83935981, content=审稿速度:1.0 经验分享：期刊很不错，值得一投。审稿人意见很中肯，需要足够的创新性！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Thu Nov 16 17:20:39 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835621, encodeId=b849835621b8, content=很好的期刊，工程领域影响力比较大，编辑和审稿人（共两个审稿人）都很专业，也很负责，2016年9月25日投稿，11月12日返回审稿意见（一个中修，一个大修），编辑给的大修；2017年1月11日投回，2月14日返回审稿意见（一个接收，一个小修），编辑给的小修；2月16日投回，2月21日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Wed Feb 22 15:39:33 CST 2017, time=2017-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833455, encodeId=08358334557a, content=创新性不足，直接拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4935414017, createdName=ms7761655755119078, createdTime=Thu Aug 25 10:31:21 CST 2016, time=2016-08-25, status=1, ipAttribution=)]

2017-02-22 ms8933482113232354

很好的期刊，工程领域影响力比较大，编辑和审稿人（共两个审稿人）都很专业，也很负责，2016年9月25日投稿，11月12日返回审稿意见（一个中修，一个大修），编辑给的大修；2017年1月11日投回，2月14日返回审稿意见（一个接收，一个小修），编辑给的小修；2月16日投回，2月21日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！

85 0

[GetPortalCommentsPageByObjectIdResponse(id=1091611, encodeId=f7f610916114e, content=选刊时有哪些需要避免的雷区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091612, encodeId=94391091612f5, content=哪些期刊是公认的水刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856940, encodeId=cc5a8569405b, content=审稿速度:1.0 经验分享：投tip被拒后，直接改投tbme，一审36天，拒稿重投，但其实2个审稿人没有给太多意见，修了2个月左右返回，二审21天直接接受。总体感觉还不错，但由于收稿范围很广，碰到小同行的概率相对较低。此外，比较好奇6楼怎么判断审稿意见是大修还是小修，审稿意见没有明确标注。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Jan 17 17:46:59 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850431, encodeId=9a9c850431b7, content=生物医学工程领域的老牌期刊，级别较高，影响力大，圈内认可度高。本次投稿很幸运能够录用，一审两个月，两个审稿人提了很多意见，编辑给的major revision。第二次审了三个月和直接录用。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Fri Mar 22 22:47:17 CST 2019, time=2019-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846882, encodeId=16cb84688257, content=很幸运能够录用。编辑和审稿人（共两个审稿人）都很nice，2018年4月29日投稿，5月29日返回审稿意见（一个小修，一个大修），编辑给的大修；7月6日投回，8月14日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Sun Sep 02 10:56:47 CST 2018, time=2018-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553850, encodeId=ab2955385017, content=您好.期刊***址有吗?我找不到zagzlh 2011-06-28 15:50:00 发表: , beContent=zagzlh 2011-06-28 15:50:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a0e2229174, createdName=2453381967_77778861, createdTime=Mon Mar 19 00:00:00 CST 2018, time=2018-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839456, encodeId=a9d683945671, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：已经三个星期了，一直under review……不知道要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=470b5414019, createdName=ms8494960720180498, createdTime=Wed Nov 22 10:27:44 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839359, encodeId=e75f83935981, content=审稿速度:1.0 经验分享：期刊很不错，值得一投。审稿人意见很中肯，需要足够的创新性！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Thu Nov 16 17:20:39 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835621, encodeId=b849835621b8, content=很好的期刊，工程领域影响力比较大，编辑和审稿人（共两个审稿人）都很专业，也很负责，2016年9月25日投稿，11月12日返回审稿意见（一个中修，一个大修），编辑给的大修；2017年1月11日投回，2月14日返回审稿意见（一个接收，一个小修），编辑给的小修；2月16日投回，2月21日接收。总的来说，期刊挺好的，审稿1个月左右，编辑和审稿人很专业，对文章的提高有很大帮助！值得一投！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Wed Feb 22 15:39:33 CST 2017, time=2017-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833455, encodeId=08358334557a, content=创新性不足，直接拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4935414017, createdName=ms7761655755119078, createdTime=Thu Aug 25 10:31:21 CST 2016, time=2016-08-25, status=1, ipAttribution=)]

2016-08-25 ms7761655755119078

创新性不足，直接拒稿。

79 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务